Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Research

Free Access

WITHDRAWN: Cardiac Troponin T: An Early Molecule Marker of Normalization of Left Ventricular Ejection Fraction in Patients with Peripartum Cardiomyopathy

Li Y.-B.a · Hu C.-L.b · Zhang J.-M.c · Zou Y.-G.d · Tang Y.-H.b · Chen J.-B.b · Tang Q.-Z.b · Huang C.-X.b

Author affiliations

Departments of aObstetrics and Gynecology and bCardiology, Renmin Hospital of Wuhan University, cDepartment of Cardiology, Wuhan Xiehe Hospital, Huazhong University of Science and Technology, Wuhan, and dDepartment of Cardiology, Xiaogan General Hospital, Xiaogan, PR China

Corresponding Author

Cong-Xin Huang, MD

Department of Cardiology, Renmin Hospital of Wuhan University

238 Jiefang Road

Wuhan 430060 (PR China)

Tel. +86 27 8804 1911, Fax +86 27 8823 7987, E-Mail yanboli72@yahoo.com.cn

Related Articles for ""

Cardiology 2007;108:345–350

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

The article entitled, "Cardiac Troponin T: An Early Molecule Marker of Normalization of Left Ventricular Ejection Fraction in Patients with Peripartum Cardiomyopathy", by Li et al, which originally was published in this space, has been removed because an article by the same authors and reporting very similar work already has been published in HEART [Published Online First: 25 October 2006], entitled, "Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy", by Hu et al. The printed version of the article in HEART can be found at Heart 2007;93:488-490.


References

  1. Phillips SD, Warnes CA: Peripartum cardiomyopathy: current therapeutic perspectives. Curr Treat Options Cardiovasc Med 2004;6:481–488.
  2. Murali S, Baldisseri MR: Peripartum cardiomyopathy. Crit Care Med 2005;33:S340–S346.
    External Resources
  3. de Souza JL Jr, de Carvalho Frimm C, Nastari L, Mady C: Left ventricular function after a new pregnancy in patients with peripartum cardiomyopathy. J Card Fail 2001;7:30–35.
  4. Veille JC: Peripartum cardiomyopathies: a review. Am J Obstet Gynecol 1984;148:805–818.
  5. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM: Natural course of peripartum cardiomyopathy. Circulation 1971;44:1053–1061.
  6. Lampert MB, Lang RM: Peripartum cardiomyopathy. Am Heart J 1995;130:860–870.
  7. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183–1188.
  8. Dorbala S, Brozena S, Zeb S, Galatro K, Homel P, Ren JF, Chaudhry FA: Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr 2005;18:45–48.
  9. Fett JD, Christie LG, Carraway RD, Murphy JG: Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005;80:1602–1606.
  10. Missov E, Mair J: A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J 1999;138:95–99.
  11. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A: Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050–2055.
  12. Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU: Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005;105:1303–1308.
  13. Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, Kataoka K, Ito H, Matsumori A, Sasayama S, Takatsu Y: Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001;103:369–374.
  14. Sato Y, Kataoka K, Matsumori A, Sasayama S, Yamada T, Ito H, Takatsu Y: Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. Heart 1997;78:505–508.
  15. Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T, Matsumori A, Takatsu Y: Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart 2003;89:659–960.
  16. Soongswang J, Durongpisitkul K, Nana A, Laohaprasittiporn D, Kangkagate C, Punlee K, Limpimwong N: Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children. Pediatr Cardiol 2005;26:45–49.
  17. Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, Hameed A, Gviazda I, Shotan A: Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567–1571.
  18. Lowbeer C, Stenvinkel P, Pecoits-Filho R, Heimburger O, Lindholm B, Gustafsson SA, Seeberger A: Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 2003;253:153–160.
  19. Seftel H, Susser M: Maternity and myocardial failure in African women. Br Heart J 1961;23:43–52.
  20. O’Connell JB, Costanzo-Nordin MR, Subramanian R, Robinson JA, Wallis DE, Scanlon PJ, Gunnar RM: Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol 1986;8:52–56.
  21. Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA: Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006;27:441–446.
  22. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A: Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050–2055.
  23. Witlin AG, Mabie WC, Sibai BM: Peripartum cardiomyopathy: a longitudinal echocardiographic study. Am J Obstet Gynecol 1997;177:1129–1132.
  24. Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU: Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005;105:1303–1308.
  25. Cole P, Cook F, Plappert T, Saltzman D, St John Sutton M: Longitudinal changes in left ventricular architecture and function in peripartum cardiomyopathy. Am J Cardiol 1987;60:871–876.
  26. Walsh JJ, Burch GE, Black WC, Ferrans VJ, Hibbs RG: Idiopathic myocardiopathy of the puerperium (postpartal heart disease). Circulation 1965;32:19–31.
  27. McNeil AR, Marshall M, Ellis CJ, Hawkins RC: Why is troponin T increased in the serum of patients with end-stage renal disease? Clin Chem 1998;44:2377–2378.
  28. Hibbard JU, Lindheimer M, Lang RM: A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999;94:311–316.
  29. Ardehali H, Kasper EK, Baughman KL: Peripartum cardiomyopathy. Minerva Cardioangiol 2003;51:41–48.
  30. Mehta NJ, Mehta RN, Khan IA: Peripartum cardiomyopathy: clinical and therapeutic aspects. Angiology 2001;52:759–762.
  31. Perna ER, Macin SM, Canella JP, Augier N, Stival JL, Cialzeta JR, Pitzus AE, Garcia EH, Obregon R, Brizuela M, Barbagelata A: Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation 2004;110:2376–2382.
  32. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P: Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000;35:701–705.

Article / Publication Details

First-Page Preview
Abstract of Original Research

Published online: February 13, 2007
Issue release date: November 2007

Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 1

ISSN: 0008-6312 (Print)
eISSN: 1421-9751 (Online)

For additional information: https://www.karger.com/CRD


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.